Treatment of human herpesvirus infections with special reference to encephalitis.
D000212:Acyclovir / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D002644:Chickenpox / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004660:Encephalitis / Q000188:drug therapy*; D005260:Female; D006558:Herpes Genitalis / Q000188:drug therapy; D006560:Herpes Labialis / Q000188:drug therapy; D006561:Herpes Simplex / Q000151:congenital / Q000188:drug therapy / Q000517:prevention & control; D006562:Herpes Zoster / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use; D007231:Infant, Newborn; D007635:Keratitis, Dendritic / Q000188:drug therapy; D007637:Keratoconjunctivitis / Q000188:drug therapy; D008297:Male; D014740:Vidarabine / Q000627:therapeutic use
D000998:Antiviral Agents; D014740:Vidarabine; D007065:Idoxuridine; D000212:Acyclovir